Kailuan Study Redefines Life-Course Cardiovascular Research with Two Decades of Real-World Evidence
en-GBde-DEes-ESfr-FR

Kailuan Study Redefines Life-Course Cardiovascular Research with Two Decades of Real-World Evidence

22/11/2026 HEP Journals

Most large-scale cohorts rely on static baseline measures, limiting insight into the dynamic progression of non-communicable diseases. The Kailuan Study, embedded within an industrial community in Tangshan, China, was designed to fill this gap through rolling enrollment, repeated biennial assessments, and linkage to comprehensive healthcare and insurance systems.
Since its inception, the cohort has grown from 101,510 to over 170,000 participants, capturing more than 22,000 cardiovascular events, 8,000 cancers, and 24,000 deaths by December 2023. Key findings have mapped the temporal sequence from metabolic dysfunction to clinical disease, established obesity as an independent risk factor for cardiac conduction block, and demonstrated that early-onset diabetes and metabolic dysfunction-associated steatotic liver disease (MASLD) markedly increase long-term risk. The study also evaluated real-world effectiveness of workplace-based hypertension management and statin therapy, with evidence cited in over 160 international clinical guidelines.
The Kailuan Study offers a robust framework for life-course epidemiology and multimorbidity research. Its integration of multi-omics, advanced imaging, and artificial intelligence-driven analytics positions it to develop comprehensive health management models. For clinicians and policymakers, this cohort delivers actionable evidence that prevention strategies must begin early, address dynamic risk trajectories, and be tailored to specific populations and settings.
The work titled “Cohort Profile: the Kailuan Study”, was published on Cardiac Research (accepted on May. 25, 2026).
DOI:10.1097/re9.0000000000000021
22/11/2026 HEP Journals
Regions: Asia, China
Keywords: Science, Life Sciences

Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

Témoignages

We have used AlphaGalileo since its foundation but frankly we need it more than ever now to ensure our research news is heard across Europe, Asia and North America. As one of the UK’s leading research universities we want to continue to work with other outstanding researchers in Europe. AlphaGalileo helps us to continue to bring our research story to them and the rest of the world.
Peter Dunn, Director of Press and Media Relations at the University of Warwick
AlphaGalileo has helped us more than double our reach at SciDev.Net. The service has enabled our journalists around the world to reach the mainstream media with articles about the impact of science on people in low- and middle-income countries, leading to big increases in the number of SciDev.Net articles that have been republished.
Ben Deighton, SciDevNet
AlphaGalileo is a great source of global research news. I use it regularly.
Robert Lee Hotz, LA Times

Nous travaillons en étroite collaboration avec...


  • The Research Council of Norway
  • SciDevNet
  • Swiss National Science Foundation
  • iesResearch
Copyright 2026 by DNN Corp Terms Of Use Privacy Statement